pyrroles has been researched along with Plasmodium falciparum Malaria in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Andrew, AK; Cooper, CA; Moore, JM; Morffy Smith, CD; Russ, BN | 1 |
| Angulo-Barturen, I; Barker, H; Burrows, JN; Charman, SA; Chen, G; Chittimalla, R; Chiu, FCK; Crighton, E; Deng, X; El Mazouni, F; Ferrer, S; Huertas-Valentin, L; Jimenez-Diaz, MB; Katneni, K; Kokkonda, S; Lafuente-Monasterio, MJ; Martinez-Martinez, MS; Matthews, D; McLaren, J; Palmer, MJ; Phillips, MA; Rathod, PK; Shackleford, DM; Shahi, SP; Tomchick, D; Waterson, D; White, J; White, KL; Wittlin, S | 1 |
| Abdullahi, M; Arang, N; Austin, LS; Billman, ZP; Douglass, AN; Hume, JCC; Kain, HS; Kappe, SHI; Kaushansky, A; Mikolajczak, SA; Murphy, SC | 1 |
| Bienvenu, AL; Picot, S | 1 |
| Amalvict, R; Baret, E; Briolant, S; Dormoi, J; Gil, M; Henry, M; Parquet, V; Pradines, B; Rogier, C; Wurtz, N | 1 |
| Cassera, MB; Hazleton, KZ; Schramm, VL; Zhang, Y | 1 |
| Büchhold, C; Ehlers, M; Gelhaus, C; Langolf, S; Machon, U; Rosenthal, PJ; Schirmeister, T; Schmuck, C; Sicking, W | 1 |
| Davis, TM; Hamzah, J; Skinner-Adams, TS | 1 |
| Baret, E; Briolant, S; Fontaine, A; Fusai, T; Henry, M; Mosnier, J; Pradines, B; Rogier, C; Torrentino-Madamet, M | 1 |
1 review(s) available for pyrroles and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Purine and pyrimidine pathways as targets in Plasmodium falciparum.
Topics: Antimalarials; Binding Sites; Drug Design; Enzyme Inhibitors; Humans; Malaria, Falciparum; Models, Molecular; Plasmodium falciparum; Protein Binding; Protozoan Proteins; Purine Nucleosides; Purines; Pyrimidines; Pyrimidinones; Pyrroles; Substrate Specificity | 2011 |
8 other study(ies) available for pyrroles and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
A novel murine model for assessing fetal and birth outcomes following transgestational maternal malaria infection.
Topics: Animals; Cell Survival; Chromosome Pairing; Disease Models, Animal; Female; Finite Element Analysis; Malaria; Malaria, Falciparum; Mice; Nerve Regeneration; Polymers; Pregnancy; Pregnancy Complications, Parasitic; Pyrroles; Tissue Scaffolds | 2019 |
Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria.
Topics: Animals; Antimalarials; Cell Line, Tumor; Crystallography, X-Ray; Dihydroorotate Dehydrogenase; Dogs; Enzyme Inhibitors; Female; Humans; Malaria, Falciparum; Male; Mice, SCID; Microsomes, Liver; Molecular Structure; Oxidoreductases Acting on CH-CH Group Donors; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Protein Binding; Pyrroles; Rats; Structure-Activity Relationship | 2020 |
Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites.
Topics: Animals; Antimalarials; Cell Line; Disease Models, Animal; Female; Imidazoles; Indoles; Life Cycle Stages; Liver; Malaria; Malaria, Falciparum; Mice; Mice, Transgenic; Parasite Load; Piperazines; Plasmodium; Plasmodium falciparum; Post-Exposure Prophylaxis; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Tumor Suppressor Protein p53 | 2015 |
Statins alone are ineffective in cerebral malaria but potentiate artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atorvastatin; Disease Models, Animal; Drug Synergism; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Malaria, Cerebral; Malaria, Falciparum; Mice; Neuroprotective Agents; Pravastatin; Pyrroles; Simvastatin | 2008 |
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.
Topics: Antimalarials; Atorvastatin; ATP-Binding Cassette Transporters; Drug Resistance; Drug Synergism; Gene Dosage; Genetic Variation; Genotype; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inhibitory Concentration 50; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Pyrroles; Quinine | 2010 |
Development of antitrypanosomal and antiplasmodial nonpeptidic cysteine protease inhibitors based on N-protected-guanidino-furan and -pyrrole building blocks.
Topics: Animals; Antimalarials; Cysteine Proteinase Inhibitors; Furans; Guanidines; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrroles; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis | 2011 |
In vitro antimalarial activity of retinoids and the influence of selective retinoic acid receptor antagonists.
Topics: Animals; Anthracenes; Antimalarials; Benzoates; Chromans; Drug Interactions; Hypoxanthine; Inhibitory Concentration 50; Malaria, Falciparum; Plasmodium falciparum; Pyrroles; Receptors, Retinoic Acid; Retinoids; Tretinoin; Vitamin A | 2003 |
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
Topics: Animals; Antimalarials; Atorvastatin; Dose-Response Relationship, Drug; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrroles; Structure-Activity Relationship | 2007 |